3C Integrity

Serialisation expert, Christoph Krähenbühl, 3C Integrity, deconstructs the final draft Delegated Act to summarise the key actions required by pharma manufacturers in implementing serialisation programmes Read more


Two's company: Two former AstraZeneca serialisation specialists have launched training to guide pharma companies Read more


The need for pharmaceutical manufacturers to act now in order to meet the requirements of the EU Falsified Medicines Directive (FMD) and still be able to sell their products throughout Europe after 2017 will be the key theme of a seminar at the... Read more